DiaCarta receives CE/IVD marking for variant detection test
DiaCarta, a molecular diagnostics company and developer of oncology tests using liquid biopsy has received CE/IVD marking for its new QuantiVirus SARS-CoV-2 Variant Detection Test.
Read the full article at: www.med-technews.com
Who We Are
Omnica Corporation is a privately-held design, engineering, and medical product development firm located in Irvine, California. The 28-person company is staffed with full-time employees and has been in operation since 1984. Our speciality is custom product development for the medical industry and industrial fields.
Our expertise is developing complex medical devices.Technical personnel at Omnica includes designers, mechanical engineers, electronic and software engineers, advanced R&D specialists, regulatory staff (for FDA documentation), machinists and model makers.